| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3089 |
| Trial ID | NCT05436223 |
| Disease | B-Cell Non-Hodgkin's Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Phase2 |
| Recruitment status | Recruiting |
| Title | Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma |
| Year | 2022 |
| Country | China |
| Company sponsor | Hrain Biotechnology Co., Ltd. |
| Other ID(s) | HRAIN01-NHL01-Ⅱ |
| Cohort 1 | |||||||||||
|
|||||||||||